The study results appeared in the July issue of The Lancet. HPV infection is known to cause virtually all cervical cancers, most anal cancers and some genital cancers. It has recently been established as a cause of the majority of oropharyngeal cancers, a malignancy of the tonsils and base of tongue. HPV-related oropharyngeal cancer is rare, but rates have been increasing rapidly, especially among men…
The results have been published in the online edition of Cell Reports. Cell growth The ability of cells to grow is directly related to the amount of protein synthesized by ribosomes, the intracellular machinery responsible for translating messenger RNA transcribed from DNA into amino acids containing proteins. …
source : http://www.foxnews.com/health/2013/07/03/10-things-should-be-doing-to-boost-your-immunity/
source : http://www.foxnews.com/health/2013/07/02/red-meat-tied-to-worse-colon-cancer-outcomes-study-finds/
"We are the first to identify this entirely new way that cancer spreads," says senior author Dr. Lorenzo Ferri, MUHC director of the Division of Thoracic Surgery and the Upper Gastrointestinal (GI) Cancer Program. "What’s equally exciting is medications already exist that are being used for other non-cancer diseases, which may prevent this mechanism of cancer spread or metastasis." According to Dr. …
Previous research from the laboratories of the senior authors Eileen P. White, PhD, associate director for basic science at the Cancer Institute of New Jersey and Joshua D. Rabinowitz, MD,PhD, professor of chemistry at Princeton University and Cancer Institute of New Jersey member, revealed that autophagy dependence is prevalent in cancers with Ras mutations. These mutations are activated in aggressive cancers with poor outcomes, such as lung…
source : http://www.foxnews.com/health/2013/07/01/differences-between-sexes-stretches-to-fitness-formulas/
"Most patients with early-stage, ER-positive breast cancer remain cancer-free after five years of tamoxifen treatment, but they remain at risk of recurrence for 15 years or longer after their initial treatment," says Dennis Sgroi, MD, of the MGH Cancer Center and Department of Pathology, lead and corresponding author of the report. "Our biomarker identifies the subgroup of patients who continue to be at risk of recurrence after tamoxifen treatment and who will benefit from extended therapy with letrozole, which should allow many women to avoid unnecessary extended treatment." Previous research by Sgroi’s team, in collaboration with investigators from bioTheranostics Inc., discovered that the ratio between levels of expression of two genes — HOXB13 and IL17BR — in tumor tissue predicted the risk of recurrence of ER-positive, lymph-node-negative breast cancer, whether or not the patient was treated with tamoxifen. …
However, new research conducted by Texas Tech University scientists has found that low doses of both chemicals together — even at levels low enough to be considered "safe" for humans if they were on their own — can cause cancer in prostate cells. The combination of the two chemicals was almost twice as likely to create cancer in prostate cells, the research found. The study published online in the peer-reviewed journal The Prostate. Kamaleshwar Singh, an assistant professor at The Institute of Environmental and Human Health (TIEHH) at Texas Tech said the findings could have an impact on health regulations regarding the "safe" doses of these chemicals and others…
"For patients with melanoma, survival beyond 10 years without a recurrence has been considered nearly synonymous with a cure," said principal investigator Mark Faries, MD, FACS, a professor of surgery at the John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, CA. "However, most studies do not follow up patients longer than 10 years. Our study found that late melanoma recurrence is not rare and that it occurs more frequently in certain patient groups." Patients with a higher chance of melanoma — the deadliest form of skin cancer — recurring more than a decade later, compared with early recurrence of melanoma within the first three years, were typically a younger age at initial diagnosis and generally exhibited less serious characteristics of the original tumor, Dr. Faries and colleagues reported…